plain language summaries

Oxford PharmaGenesis was proud to represent HealthScience communication at the Institute of Directors (IoD) Summer Reception, held in the delightful setting of the Terrace Pavilion at the House of Commons in London on Monday 29 June. Commercial Director Dr Richard White was one of a select group of IoD members from around the country, who […]

This month’s issue of Director magazine – the official publication of the UK Institute of Directors (IoD) – includes an interview with Dr Richard White, Commercial Director at Oxford PharmaGenesis. In the feature article, which profiles the IoD’s business information and advisory services, Richard describes how Oxford PharmaGenesis has used these services to address specific […]

It’s been said that Professor Brian Cox has a brain the size of a planet, but you don’t need to look to the heavens to revel in numbers of astronomical proportions. Look inside his skull and you’d find 100 billion neurones plus another 100 billion supporting cells, which together form the blancmange that is the […]

Oxford PharmaGenesis today celebrates winning the Queen’s Award for Enterprise. This honour, the UK’s highest accolade for business success, is awarded by the Queen on the advice of the Prime Minister, and is publicly announced on Her Majesty’s birthday. The global consultancy receives the award for Outstanding Achievement in International Trade, having more than doubled […]

Oxford PharmaGenesis has recently held a fundraising event in Oxford and London, for Purple Day, an international initiative to increase awareness about epilepsy. To mark the day, staff wore purple to show their support for people living with this condition.

Oxford PharmaGenesis has recently joined OBN, the UK membership organization for innovative life science R&D companies in the golden triangle of Oxford, Cambridge and London – and beyond. Chris Winchester, Managing Director of Oxford PharmaGenesis, comments, “We are proud to be part of a support network for emerging life-science companies and offer our communications expertise.”

Real-world evidence (RWE) study publications and clinical trial data disclosure were two major topics of discussion at the 14th Annual Meeting of The International Publication Planning Association (TIPPA), with both keynote sessions being led by Oxford PharmaGenesis. The meeting, held in San Diego on 9–10 February 2015, was attended by an approximately even mix of […]

Did you know that 1 in 10 people in the USA are living with a rare disease? To put it in perspective, that’s approximately the same as the number of people who are left-handed! Rare diseases don’t discriminate – they affect all races and religions, rich and poor, young and old. They are often chronic […]

Our company Chairman and founder, Graham Shelton, is taking up a different challenge next month by taking part in The Rotary Club of Oxford North Charity Rowathon. This will involve rowing the distance of the Oxford and Cambridge Boat Race for the charity SSNAP, which supports sick and premature babies and their families.

A consensus article co-authored by researchers from the European Society for Primary Care Gastroenterology and Oxford PharmaGenesis is in the top 10 most accessed papers in a leading gastroenterology journal. The systematic-review-based consensus article breaks new ground by summarizing complex information for clinicians in primary care regarding the use of probiotics in the treatment of […]